10:57 AM
 | 
Feb 22, 2019
 |  BC Week In Review  |  Company News  |  Deals

SCM, Genexine purchase Argos

SCM Lifescience (Incheon, South Korea) and Genexine Inc. (KOSDAQ:095700) purchased all assets of Argos Therapeutics Inc. (Durham, N.C.) for $11.3 million and will rename the company CoImmune Inc.

SCM will own 51%...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >